BUSINESSNatco Pharma Gains 9%, Launches Generic Version of Revlimid in USadminMarch 8, 2022March 8, 2022 March 8, 2022March 8, 2022 Shares of Natco Pharma rallied 9 per cent to Rs 920 on the BSE in Tuesday’s intra-day trade after the company launched its first generic...